| 1. |
- Wang, Yuying, et al.
(författare)
-
The prevalence of adverse reactions among individuals with three-dose COVID-19 vaccination
- 2023
-
Ingår i: Journal of Infection and Public Health. - : Elsevier BV. - 1876-0341. ; 16:1, s. 125-132
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Considering the adverse reactions to vaccination against coronavirus disease 2019 (COVID-19), some people, particularly the elderly and those with underlying medical conditions, are hesitant to be vaccinated. This study aimed to explore the prevalence of adverse reactions and provide direct evidence of vaccine safety, mainly for the elderly and people with underlying medical conditions, to receive COVID-19 vaccination. Methods: From 1st March to 30th April 2022, we conducted an online survey of people who had completed three doses of COVID-19 vaccination by convenience sampling. Adverse reaction rates and 95% confidence intervals were calculated. In addition, conditional logistic regression was used to compare the differences in adverse reactions among the elderly and those with underlying medical conditions with the general population. Results: A total of 3339 individuals were included in this study, of which 2335 (69.9%) were female, with an average age of 32.1 ± 11.4 years. The prevalence of adverse reactions after the first dose of inactivated vaccine was 24.6% (23.1–26.2%), 19.2% (17.8–20.7%) for the second dose, and 19.1% (17.7–20.6%) for the booster dose; among individuals using messenger RNA vaccines, the prevalence was 42.7% (32.3–53.6%) for the first dose, 47.2% (36.5–58.1%) for the second dose, and 46.1% (35.4–57.0%) for the booster dose. Compared with the general population, the prevalence of adverse events did not differ in individuals with underlying medical conditions and those aged 60 and above. Conclusions: For individuals with underlying medical conditions and those aged 60 and above, the prevalence of adverse reactions is similar to that of the general population, which provides a scientific basis regarding vaccination safety for these populations.
|
|
| 2. |
- Visvanathan, Kala, et al.
(författare)
-
Circulating vitamin D and breast cancer risk : an international pooling project of 17 cohorts
- 2023
-
Ingår i: European Journal of Epidemiology. - : Springer Science+Business Media B.V.. - 0393-2990 .- 1573-7284. ; 38, s. 11-29
-
Tidskriftsartikel (refereegranskat)abstract
- Laboratory and animal research support a protective role for vitamin D in breast carcinogenesis, but epidemiologic studies have been inconclusive. To examine comprehensively the relationship of circulating 25-hydroxyvitamin D [25(OH)D] to subsequent breast cancer incidence, we harmonized and pooled participant-level data from 10 U.S. and 7 European prospective cohorts. Included were 10,484 invasive breast cancer cases and 12,953 matched controls. Median age (interdecile range) was 57 (42–68) years at blood collection and 63 (49–75) years at breast cancer diagnosis. Prediagnostic circulating 25(OH)D was either newly measured using a widely accepted immunoassay and laboratory or, if previously measured by the cohort, calibrated to this assay to permit using a common metric. Study-specific relative risks (RRs) for season-standardized 25(OH)D concentrations were estimated by conditional logistic regression and combined by random-effects models. Circulating 25(OH)D increased from a median of 22.6 nmol/L in consortium-wide decile 1 to 93.2 nmol/L in decile 10. Breast cancer risk in each decile was not statistically significantly different from risk in decile 5 in models adjusted for breast cancer risk factors, and no trend was apparent (P-trend = 0.64). Compared to women with sufficient 25(OH)D based on Institute of Medicine guidelines (50– < 62.5 nmol/L), RRs were not statistically significantly different at either low concentrations (< 20 nmol/L, 3% of controls) or high concentrations (100– < 125 nmol/L, 3% of controls; ≥ 125 nmol/L, 0.7% of controls). RR per 25 nmol/L increase in 25(OH)D was 0.99 [95% confidence intervaI (CI) 0.95–1.03]. Associations remained null across subgroups, including those defined by body mass index, physical activity, latitude, and season of blood collection. Although none of the associations by tumor characteristics reached statistical significance, suggestive inverse associations were seen for distant and triple negative tumors. Circulating 25(OH)D, comparably measured in 17 international cohorts and season-standardized, was not related to subsequent incidence of invasive breast cancer over a broad range in vitamin D status.
|
|
| 3. |
|
|
| 4. |
- Zhou, Yao, et al.
(författare)
-
Enabling High-Performance Polypropylene Nanocomposites With Interfacial Deep Traps
- 2023
-
Ingår i: IEEE Transactions on Dielectrics and Electrical Insulation. - 1558-4135 .- 1070-9878. ; 30:1, s. 484-487
-
Tidskriftsartikel (refereegranskat)abstract
- Polymer nanocomposites are the material of choice for dc insulation. The emerging demand for high-capacity high voltage direct current (HVdc) power transmission requires polymer nanocomposites capable of safe and stable operation at high temperatures. However, the high-temperature electrical properties of current polymer nanocomposites are still unsatisfactory. Here, we report that the modulation of polymer/nanoparticle interfaces can greatly improve the high-temperature insulation properties of polypropylene (PP)-based nanocomposite for recyclable HVdc cable insulation application. The nanoparticles are surface-modified with PP-graft-maleic anhydride (PP- g -mah), which is not only well miscible with PP but also contains polar groups to act as interfacial deep traps. We demonstrate that the interfacial deep traps can improve the dc breakdown strength and the electrical resistivity of polymer nanocomposite by inhibiting the charge injection. This work deepens the understanding of interfacial effects in polymer nanocomposites and provides new opportunities for designing high-performance recyclable insulation materials for HVdc cables.
|
|
